ObjectiveTo assess the value of comfortable and maximum walking speed of outcome measuring for locomotion recovery after stroke.Methods10m walking speed of 32 stroke subjects who were able to walk independently were tested in the freely chosen and maximum. The motor function of the paretic lower limb and balance were evaluated with the Fugl-Meyer Assessment,Berg Balance Scale and ambulatory item of Functional Independence Measure. The level of association between gait speeds and the clinical variables were examined with Pearson's correlation coefficients.ResultsComfortable walking speed were significantly positively related to maximum walking speed(r=0.953,P<0.001),and balance, motor function of the lower limb and ambulatory function were significantly positively related to comfortable and maximum walking speed(r=0.742-0.834,P<0.001).The relationship between comfortable walking speed and clinical variables was higher(r=0.787-0.834,P<0.001).Conclusions Both comfortable and maximum walking speed can reflect locomotion recovery after stroke, but comfortable walking speed is more pragmatic,securer and more sensitive.

Respiratory tract infection is the most common disease in children, and it is also the most common disease of irrational use of antibiotics.The rational application of antibiotics is to reduce the rate of bacterial resistance and its adverse events.The emergence of drug-resistant strains is closely related to the wide application of antibiotics.In order to reduce the irrational use of antibiotics in children′s respiratory tract infection, pediatricians need to know the timing of application of antibiotics.The respiratory tract infection can be divided into upper respiratory tract infection and lower respiratory tract infection, including common cold, pharyngitis, sinusitis, otitis media, bronchitis and bronchitis, and pneumonia.This article reviews the application timing of antibiotics in the common respiratory tract infection of these children.

The role of glial scar after intracerebral hemorrhage(ICH)remains unclear.This study aimed to inves-tigate whether microglia-astrocyte interaction affects glial scar formation and explore the specific function of glial scar.We used a pharmacologic approach to induce microglial depletion during different ICH stages and examine how ablating microglia affects astrocytic scar formation.Spatial transcriptomics(ST)analysis was performed to explore the potential ligand-receptor pair in the modulation of microglia-astrocyte interaction and to verify the functional changes of astrocytic scars at different periods.During the early stage,sustained microglial depletion induced disorganized astrocytic scar,enhanced neutrophil infiltration,and impaired tissue repair.ST analysis indicated that microglia-derived insulin like growth factor 1(IGF1)modulated astrocytic scar formation via mechanistic target of rapamycin(mTOR)signaling activation.Moreover,repopulating microglia(RM)more strongly activated mTOR signaling,facilitating a more protective scar formation.The combination of IGF1 and osteopontin(OPN)was necessary and sufficient for RM function,rather than IGF1 or OPN alone.At the chronic stage of ICH,the overall net effect of astrocytic scar changed from protective to destructive and delayed microglial depletion could partly reverse this.The vital insight gleaned from our data is that sustained microglial depletion may not be a reasonable treatment strategy for early-stage ICH.Inversely,early-stage IGF1/OPN treatment combined with late-stage PLX3397 treatment is a promising therapeutic strategy.This prompts us to consider the complex temporal dynamics and overall net effect of microglia and astrocytes,and develop elaborate treatment strategies at precise time points after ICH.